- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04277078
Predicting Intubation of Patients Hospitalised for Acutely Attacked Asthma
June 28, 2020 updated by: Narongwit Nakwan, Hat Yai Medical Education Center
Predicting Factors of Intubation in Hospitalised Patients With Acutely Attacked Asthma
Although the asthmatic treatments currently be effective in term of efficacy of inhaled medications and good clinical outcome including symptom controlled and asthma exacerbation number, the large number of worse event still have been reported.
Few cases eventually have been intubated and died even though using optimal medication.
In this study, we will search to identify factors that may influence intubation in hospitalised patient with asthmatic attack.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
509
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Songkhla
-
Hat Yai, Songkhla, Thailand, 90110
- Hatyai Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Population in this study is a the patient who had been admitted with moderate to severe asthmatic attack.
The study will be retrospective review with data in medical record between year 2016-2018.
The baseline characteristic and factors which has a potential to intubation will be recored.
Description
Inclusion Criteria:
- Patients who had been admitted and diagnosed as asthmatic attack between year 2016-2018.
- Patients who have age > 15 year old.
Exclusion Criteria:
- Non
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Intubated asthma attack
Patients who had been hospitalised with asthma attack, then intubated during hospitalisation.
|
Non-Intubated asthma attack
Patients who had been hospitalised with asthma attack without intubation during hospitalisation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number case of intubated patient
Time Frame: Retropectively review 2 years backard between 2017-2018
|
Number case of hospitalized asthmatic attack patients during 2-year review.
|
Retropectively review 2 years backard between 2017-2018
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of previous asthma attack before this admission
Time Frame: 1 year before admission
|
Number of previous asthma attack with 12 months before this hospitalization.
|
1 year before admission
|
Blood eosinophil count at admission time
Time Frame: Retropectively review 2 years backard between 2017-2018
|
Blood eosinophil may help predict outcome and risk for intubation.
|
Retropectively review 2 years backard between 2017-2018
|
Number patients dead
Time Frame: Retropectively review 2 years backard between 2017-2018
|
Number patient dead during hospitalization
|
Retropectively review 2 years backard between 2017-2018
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Narongwit Nakwan, M.D., Hatyai Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2020
Primary Completion (Actual)
May 30, 2020
Study Completion (Actual)
May 30, 2020
Study Registration Dates
First Submitted
February 15, 2020
First Submitted That Met QC Criteria
February 18, 2020
First Posted (Actual)
February 20, 2020
Study Record Updates
Last Update Posted (Actual)
June 30, 2020
Last Update Submitted That Met QC Criteria
June 28, 2020
Last Verified
February 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 65/2562
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Universita di VeronaCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia